SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-20-024856
Filing Date
2020-11-06
Accepted
2020-11-06 16:08:21
Documents
68
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q brhc10016668_10q.htm   iXBRL 10-Q 1696362
2 EXHIBIT 31.1 brhc10016668_ex31-1.htm EX-31.1 11316
3 EXHIBIT 31.2 brhc10016668_ex31-2.htm EX-31.2 10867
4 EXHIBIT 32.1 brhc10016668_ex32-1.htm EX-32.1 5527
10 image01.jpg GRAPHIC 26227
11 image02.jpg GRAPHIC 217547
  Complete submission text file 0001140361-20-024856.txt   7495994

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rckt-20200930.xsd EX-101.SCH 48067
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rckt-20200930_cal.xml EX-101.CAL 62793
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rckt-20200930_def.xml EX-101.DEF 211644
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rckt-20200930_lab.xml EX-101.LAB 700823
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rckt-20200930_pre.xml EX-101.PRE 368474
12 EXTRACTED XBRL INSTANCE DOCUMENT brhc10016668_10q_htm.xml XML 1057926
Mailing Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118
Business Address 350 FIFTH AVENUE SUITE 7530 NEW YORK NY 10118 646-440-9100
ROCKET PHARMACEUTICALS, INC. (Filer) CIK: 0001281895 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36829 | Film No.: 201294474
SIC: 2834 Pharmaceutical Preparations